Provectus Biopharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $105.5K | $1.2M | $14.2M | $17.4M | $15.7M | $1.2M | $7.7M | $8.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $958.3K | $1.8M | $14.7M | $19.1M | $15.7M | — | $7.7M | $8.1M |
| Property, Plant & Equipment | $86.6K | $72.0K | $85.1K | $92.2K | $30.1K | $29.8K | $20.1K | $21.3K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $1.6M | $2.2M | $2.9M | $3.6M | $4.3M | $4.9M | $5.6M | $6.3M |
| Total Assets | $3.4M | $5.6M | $20.4M | $26.2M | $20.0M | $6.2M | $13.3M | $14.4M |
| Liabilities | ||||||||
| Accounts Payable | $3.3M | $1.9M | $1.9M | $440.7K | $348.9K | $243.4K | $101.1K | $418.5K |
| Total Current Liabilities | $3.6M | $2.1M | $4.1M | $847.7K | $512.9K | $511.4K | $262.7K | $1.3M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $13.5M | $2.1M | $4.1M | $994.3K | $13.4M | $1.8M | $3.3M | $3.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-218.7M | $-205.2M | $-180.8M | $-156.3M | $-146.1M | $-118.4M | $-105.8M | $-86.4M |
| Total Stockholders' Equity | $-10.0M | $3.5M | $16.3M | $25.2M | $6.6M | $4.4M | $10.0M | $10.7M |